vimarsana.com
Home
Live Updates
FDA approves Mounjaro, rebranded as Zepbound, for weight los
FDA approves Mounjaro, rebranded as Zepbound, for weight los
FDA approves Mounjaro, rebranded as Zepbound, for weight loss
The U.S. Food and Drug Administration has approved the use of another diabetes drug for chronic weight management in adults, regulators said Wednesday.
Tirzepatide — Eli Lilly’s diabetes drug approved...
Related Keywords
United States ,
Joe Nadglowski ,
John Sharretts ,
Eli Lilly ,
Obesity Action Coalition ,
Novo Nordisk ,
Drug Administration ,